Thyronamine, a new inotropic agent: its cardiovascular effects and mechanism of action.
D000818:Animals; D001285:Atropine / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects*; D002395:Catecholamines / Q000494:pharmacology; D002404:Catheterization; D004285:Dogs; D006339:Heart Rate / Q000187:drug effects*; D006352:Heart Ventricles / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D007545:Isoproterenol / Q000494:pharmacology; D009200:Myocardial Contraction / Q000187:drug effects; D009638:Norepinephrine / Q000494:pharmacology; D010138:Pacemaker, Artificial; D010627:Phenethylamines / Q000494:pharmacology*; D010643:Phenoxybenzamine / Q000494:pharmacology; D010647:Phenyl Ethers / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D012110:Reserpine / Q000494:pharmacology; D013566:Sympathomimetics / Q000494:pharmacology; D013974:Thyroxine / Q000031:analogs & derivatives / Q000494:pharmacology; D014655:Vascular Resistance / Q000187:drug effects
D002395:Catecholamines; D010627:Phenethylamines; D010647:Phenyl Ethers; D013566:Sympathomimetics; D010643:Phenoxybenzamine; D001285:Atropine; D012110:Reserpine; D011433:Propranolol; D007545:Isoproterenol; D013974:Thyroxine; D009638:Norepinephrine